These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20189477)

  • 61. A model for T cell receptor and MHC/peptide interaction.
    Davis MM; Bjorkman PJ
    Adv Exp Med Biol; 1989; 254():13-6. PubMed ID: 2816544
    [No Abstract]   [Full Text] [Related]  

  • 62. Lipid rafts and T-lymphocyte function: implications for autoimmunity.
    Kabouridis PS; Jury EC
    FEBS Lett; 2008 Nov; 582(27):3711-8. PubMed ID: 18930053
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The importance of Ca
    Diercks BP
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119710. PubMed ID: 38522726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High specificity, not degeneracy, allows T cell alloresponses.
    Nikolich-Zugich J
    Nat Immunol; 2007 Apr; 8(4):335-7. PubMed ID: 17375093
    [No Abstract]   [Full Text] [Related]  

  • 65. Surveillance states.
    Dash P; Thomas PG
    Nat Struct Mol Biol; 2017 Apr; 24(4):339-341. PubMed ID: 28384134
    [No Abstract]   [Full Text] [Related]  

  • 66. T-cell antigen receptor triggering and lipid rafts: a matter of space and time scales. Talking Point on the involvement of lipid rafts in T-cell activation.
    He HT; Marguet D
    EMBO Rep; 2008 Jun; 9(6):525-30. PubMed ID: 18516087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lymphocyte repertoire selection and intracellular self/non-self-discrimination: historical overview.
    Forsdyke DR
    Immunol Cell Biol; 2015 Mar; 93(3):297-304. PubMed ID: 25385066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New methods for assessing T-cell responses.
    Bercovici N; Duffour MT; Agrawal S; Salcedo M; Abastado JP
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):859-64. PubMed ID: 11063487
    [No Abstract]   [Full Text] [Related]  

  • 69. The role of T-cell receptor dimerization in T-cell activation.
    Bachmann MF; Ohashi PS
    Immunol Today; 1999 Dec; 20(12):568-76. PubMed ID: 10562708
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Kinetic discrimination in T-cell activation.
    Rabinowitz JD; Beeson C; Lyons DS; Davis MM; McConnell HM
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1401-5. PubMed ID: 8643643
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cytokines and T cell homeostasis.
    Sprent J; Surh CD
    Immunol Lett; 2003 Jan; 85(2):145-9. PubMed ID: 12527221
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antigen presentation: from cell biology to physiology.
    Amigorena S
    Immunol Rev; 2016 Jul; 272(1):5-7. PubMed ID: 27319337
    [No Abstract]   [Full Text] [Related]  

  • 73. Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis.
    Mabuchi T; Hirayama N
    J Invest Dermatol; 2016 Sep; 136(9):1901-1903. PubMed ID: 27189829
    [No Abstract]   [Full Text] [Related]  

  • 74. Obsessive-Compulsive Behavior Isn't Necessarily a Bad Thing.
    Marrack P
    Annu Rev Immunol; 2020 Apr; 38():1-21. PubMed ID: 31594433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MHC restriction in three dimensions: a view of T cell receptor/ligand interactions.
    Bjorkman PJ
    Cell; 1997 Apr; 89(2):167-70. PubMed ID: 9108471
    [No Abstract]   [Full Text] [Related]  

  • 76. Homeostatic expansion versus antigen-driven proliferation: common ends by different means?
    Prlic M; Jameson SC
    Microbes Infect; 2002 Apr; 4(5):531-7. PubMed ID: 11959508
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Giving Context to Non-self-marker Theories of Immune Responsiveness.
    Cohn M
    Scand J Immunol; 2017 Sep; 86(3):124-129. PubMed ID: 28671723
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The immunology connection--my first T cell receptor structure projects.
    Wang JH
    Protein Cell; 2014 Sep; 5(9):649-52. PubMed ID: 25087847
    [No Abstract]   [Full Text] [Related]  

  • 79. Experimental strategies to explore the molecular details of MHC-peptide complexes.
    Rothbard JB; Busch R; Hill CM
    Int Rev Immunol; 1990; 6(1):1-21. PubMed ID: 2102902
    [No Abstract]   [Full Text] [Related]  

  • 80. Focusing in on T cell cross-reactivity.
    Mandl JN; Germain RN
    Cell; 2014 May; 157(5):1006-8. PubMed ID: 24855938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.